These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28082103)

  • 21. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spread Through Air Spaces Is a Prognostic Factor in Sublobar Resection of Non-Small Cell Lung Cancer.
    Shiono S; Endo M; Suzuki K; Yarimizu K; Hayasaka K; Yanagawa N
    Ann Thorac Surg; 2018 Aug; 106(2):354-360. PubMed ID: 29625101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
    Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers.
    Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ
    Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.
    Razi SS; John MM; Sainathan S; Stavropoulos C
    J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete Lymphadenectomy for Clinical Stage I Lepidic Adenocarcinoma of the Lung: Is it justified?
    Maurizi G; D'Andrilli A; Argento G; Ciccone AM; Ibrahim M; Andreetti C; Vanni C; Tierno SM; Venuta F; Rendina EA
    Semin Thorac Cardiovasc Surg; 2023; 35(2):399-409. PubMed ID: 35272026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease.
    Liou DZ; Chan M; Bhandari P; Lui NS; Backhus LM; Shrager JB; Berry MF
    Eur J Cardiothorac Surg; 2022 Oct; 62(5):. PubMed ID: 36063054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.
    Mimae T; Tsutani Y; Miyata Y; Yoshiya T; Ibuki Y; Kushitani K; Takeshima Y; Nakayama H; Okumura S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1820-6. PubMed ID: 24507979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Margin Width of Resected Lepidic Lung Cancer Does Not Affect Recurrence After Sublobar Resection.
    Moon Y; Lee KY; Park JK
    World J Surg; 2018 May; 42(5):1449-1457. PubMed ID: 29043409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Ann Thorac Surg; 2023 Jun; 115(6):1344-1351. PubMed ID: 36126718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.
    Gulack BC; Yang CF; Speicher PJ; Meza JM; Gu L; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2015 Dec; 90(3):554-60. PubMed ID: 26519122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.